Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mater Sci Eng C Mater Biol Appl ; 109: 110557, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32228952

ABSTRACT

The clinical demand for bone scaffolds as an alternative strategy for bone grafting has increased exponentially and, up to date, numerous formulations have been proposed to regenerate the bone tissue. However, most of these structures lack at least one of the fundamental/ideal properties of these materials (e.g., mechanical resistance, interconnected porosity, bioactivity, biodegradability, etc.). In this work, we developed innovative composite scaffolds, based on crosslinked chitosan with glutaraldehyde (GA), combined with different atomized calcium phosphates (CaP) granules - hydroxyapatite (HA) or biphasic mixtures of HA and ß - tricalcium phosphate (ß-TCP), with improved biomechanical behavior and enhanced biological response. This innovative combination was designed to improve the scaffolds' functionality, in which GA improved chitosan mechanical strength and stability, whereas CaP granules enhanced the scaffolds' bioactivity and osteoblastic response, further reinforcing the scaffolds' structure. The biological assessment of the composite scaffolds showed that the specimens with 0.2% crosslinking were the ones with the best biological performance. In addition, the inclusion of biphasic granules induced a trend for increase osteogenic activation, as compared to the addition of HA granules. In conclusion, scaffolds produced in the present work, both with HA granules or the biphasic ones, and with low concentrations of GA, have shown adequate properties and enhanced biological performance, being potential candidates for application in bone tissue engineering.


Subject(s)
Bone and Bones/metabolism , Chitosan/chemistry , Durapatite/chemistry , Osteoblasts/metabolism , Osteogenesis , Tissue Scaffolds/chemistry , Bone and Bones/cytology , Cell Line, Tumor , Cross-Linking Reagents/chemistry , Glutaral/chemistry , Humans , Osteoblasts/cytology
2.
Int J Pharm ; 516(1-2): 185-195, 2017 Jan 10.
Article in English | MEDLINE | ID: mdl-27851979

ABSTRACT

Recently it has been shown that folic acid can have an important role in bone regeneration. For this reason, combining a classic bone regeneration system as, hydroxyapatite, loaded with folic acid, may be an important issue to be developed. To address this issue, hydroxyapatite nanoparticles loaded with folic acid were designed as an effective bone regenerative system, to induce osteoblast differentiation and improve the bone regeneration. HapNP were prepared by a hydrothermal method that used citric acid as a tailoring agent of particles morphology and, simultaneously, had the particularly to let carboxylic pendant groups in the particle surface, which provided a platform for the immobilization of folic acid (FA), producing HapNP-FA. A comparative study among hydroxyapatite nanoparticles loaded and unloaded with folic acid in presence of human mesenchymal stem cells was performed. The results demonstrate, that nanoparticles were able to be internalized by human mesenchymal stem cells. In addition, cell proliferation and viability were not affected in a wide concentration range. Both particles induced the expression of Runx2 and the expression and activity of alkaline phosphatase. However, HapNP-FA caused a significantly higher overexpression of Runx2. The osteoblastic differentiation confirms the potential applicability of HapNP-FA in the local bone regeneration.


Subject(s)
Durapatite/chemistry , Folic Acid/administration & dosage , Nanoparticles , Osteoblasts/drug effects , Alkaline Phosphatase/metabolism , Bone Regeneration/drug effects , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Citric Acid/chemistry , Folic Acid/pharmacology , Humans , Mesenchymal Stem Cells/metabolism , Osteoblasts/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...